High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis

Clinica Chimica Acta

Volumn 367, Issue 1-2, 2006, Pages 156-161

  Lemarechal, Hervé ^a   Allanore, Yannick ^a   Chenevier Gobeaux, Camille ^a   Ekindjian, Ohvanesse G ^a   Kahan, André ^a   Borderie, Didier ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Oxidative stress; Rheumatoid arthritis; Thioredoxin

Indexed keywords

CARBONYL DERIVATIVE; THIOL DERIVATIVE; THIOREDOXIN; THIOREDOXIN REDUCTASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SPECTROPHOTOMETRY;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; HUMANS; MIDDLE AGED; OXIDATION-REDUCTION; SULFHYDRYL COMPOUNDS; THIOREDOXIN; THIOREDOXIN REDUCTASE (NADPH);

EID: 33645830258     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.12.006     Document Type: Article

References (36)

1. Pap T., Muller-Ladner U., Gay R.E., and Gay S. Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2 (2000) 61-67
2. Mapp P.I., Grootveld M.C., and Blake D.R. Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull 51 (1995) 419-436
3. Hitchon C.A., and El-Gabalawy H. Oxidation in rheumatoid arthritis. Arthritis Res Ther 6 (2004) 265-278
4. Tak P.P., Zwaifler N.J., Green D.R., and Firestein G.S. Rheumatoid arthritis and P53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 21 (2000) 78-82
5. Remans P.H.J., van Ooterhout M., Smeets T.J.M., et al. Intracellular free radical production in synovial T lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 52 (2005) 2003-2009
6. Bashir S., Harris G., Denman M.A., Blake D.R., and Winyard P.G. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis 52 (1993) 659-666
7. Halliwell B. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis 54 (1995) 505-510
8. Heliovaara M., Knekt P., Aho K., Aaran R.K., Alfthan G., and Aromaa A. Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis 53 (1994) 51-53
9. Hagfors L., Leanderson P., Skoldstam L., Andersson J., and Johansson G. Antioxidant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr J 2 (2003) 5
10. Jaswal S., Metha H.C., Sood A.K., and Kaur J. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 338 (2003) 123-129
11. Gromer S., Johansson L., Bauer H., et al. Active sites of thioredoxin reductases: why selenoproteins?. Proc Natl Acad Sci U S A 100 (2003) 12618-12623
12. Söderberg A., Sahaf B., and Rosén A. Thioredoxine reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Cancer Res 60 (2000) 2281-2289
13. Holmgren A. Thioredoxins and glutaredoxin systems. J Biol Chem 264 (1989) 13963-13966
14. Norberg J., and Arner E.S.J. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Rad Biol Med 32 (2001) 1287-1312
15. Nakamura H. Thioredoxin and its related molecules: update 2005. Antioxid Redox Sign 7 (2005) 823-828
16. Watson W.H., Yang X., Choi Y.E., Jones D.P., and Kehrer J.P. Thioredoxin and its role in toxicology. Toxicol Sci 78 (2004) 3-14
17. Nakamura H., Herzenberg L.A., Bai J., et al. Circulating thioredoxin supresses lipopolysaccharide induced neutrophil chemotaxis. Proc Natl Acad Sci U S A 98 (2001) 15143-15148
18. Nakamura H., De Rosa S.C., Yodoi J., et al. Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc Natl Acad Sci U S A 5 (2003) 2688-2693
19. Maurice M.M., Nakamura H., Gringhuis S., et al. Expression of the thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 42 (1999) 2430-2439
20. Yoshida S., Katoh T., Tetsuka T., Uno K., Matsui N., and Okamoto T. Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-alpha induced production of IL-6 and IL-8 cultured synovial fibroblasts. J Immunol 163 (1999) 351-358
21. Jikimoto T., Nishikubo Y., Koshiba M., et al. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol 38 (2001) 765-772
22. Nakamura H., Vaage J., Valen G., Padilla C.A., Bjornstedt M., and Holmgren A. Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery. Free Radic Biol Med 24 (1998) 1176-1186
23. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
24. Arner E.S., Zhong L., and Holmgren A. Preparation and assay of mammalian thioredoxin and thioredoxin reductase. Methods Enzymol 300 (1999) 226-239
25. Reznick A.Z., and Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233 (1994) 357-363
26. Hu M.L. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233 (1994) 380-385
27. Miyamoto S., Kawano H., Sakamoto T., et al. Increased plasma levels of thioredoxin in patients with coronary spastic angina. Antioxid Redox Sign 6 (2004) 75-80
28. Sumida Y., Nakashima T., Yoh T., et al. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatisis C virus infection. J Hepatol 33 (2000) 616-622
29. Jekel A., Hossain A., Alehagen U., Dahlström U., and Rosen A. Elevated circulating levels of thioredoxin and stress in chronic heart failure. Eur J Heart Fail 6 (2004) 883-890
30. Ren X., Björnstedt M., Shen B., Ericson M.L., and Holmgren A. Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione. Biochemistry 32 (1993) 9701-9708
31. Renke J., Popadiuk S., Korzon M., Bugajczyk B., and Wozniak M. Protein carbonyl groups' content as useful clinical marker of antioxidant barrier impairment in plasma of children with juvenile chronic arthritis. Free Radic Bio Med 29 (2000) 101-104
32. Giustarini D., Lorenzini S., Rossi R., Chindamo D., Di Simplicio P., and Marcolongo R. Altered thiol pattern in plasma of subjects affected by rheumatoid arthritis. Clin Exp Rheumatol 23 (2005) 205-212
33. Hoshino T., Nakamura H., Okamoto M., et al. Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin induced lung injury. Am Respir Crtit Care Med 168 (2003) 10
34. Bertini R., Howard O.M., Dong H.F., et al. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med 189 (1999) 1783-1789
35. Yazar M., Sarban S., Kocyigit A., and Isikan U.E. Synovial fluid and plasma selenium, copper, zinc, and iron concentrations in patients with rheumatoid arthritis and osteoarthritis. Biol Trace Elem Res 106 (2005) 123-132
36. Zhong L., Arnér E.S., and Holmgren A. Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenylsulfide formed from the conserved cysteine-selenocysteine sequence. Proc Natl Acad Sci U S A 97 (2000) 5854-5859